It has been ten years since Jeffrey Bluestone, PhD, was recruited from the University to Chicago to lead the Diabetes Center at UCSF as the AW and Mary Margaret Clausen Distinguished Professor in Metabolism and Endocrinology. By aggressively recruiting some of the most talented basic researchers in diabetes, and by serving as the driving force behind the Diabetes Center's innovative clinical research program, Dr. Bluestone has elevated the stature of the Diabetes Center -- making it one of the top diabetes research institutions in the world.
Additionally, as a renowned immunologist, Dr. Bluestone's research has led to the discovery of immunotherapies used to treat autoimmunity and transplant rejection, and he has been a national spokesperson for the rapid discovery and translation of science to clinical practice.
Not surprisingly, Dr. Bluestone's significant accomplishments have not gone unnoticed. UCSF Chancellor Susan Desmond-Hellmann, MD, MPH, asked Dr. Bluestone to serve in the role of executive vice chancellor and provost. Recently approved by the UC Regents, Dr. Bluestone will serve as UCSF's chief academic officer, guiding the research and academic enterprise.
Even though Dr. Bluestone is serving as second in command at UCSF, he remains passionately committed to finding improved treatments and cures for diabetes. Fortunately for all of us, Dr. Bluestone will continue to manage his diabetes lab at UCSF and will continue to guide his post-doctoral fellows, research associates and technicians.
Please join us in thanking Dr. Bluestone for his vision and leadership through the years, and for his continued commitment to diabetes research. Congratulations, Jeff, on this well deserved promotion.